{"id":"NCT05425745","sponsor":"NewAmsterdam Pharma","briefTitle":"Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.","officialTitle":"A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH Who Are Not Adequately Controlled by Their Lipid Modifying Therapies","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-07-25","primaryCompletion":"2024-05-28","completion":"2024-05-28","firstPosted":"2022-06-21","resultsPosted":"2025-06-11","lastUpdate":"2025-06-11"},"enrollment":354,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dyslipidemias","High Cholesterol","Hypercholesterolemia","Familial Hypercholesterolemia","Lipid Metabolism Disorder","Metabolic Disease","Lipid Metabolism, Inborn Errors","Genetic Disease, Inborn","Hyperlipoproteinemias"],"interventions":[{"type":"DRUG","name":"Obicetrapib","otherNames":["CETP-inhibitor"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Obicetrapib 10 mg","type":"EXPERIMENTAL"}],"summary":"This study will be a placebo-controlled, double-blind, randomized, phase 3 study to Evaluate the Efficacy, Safety, and Tolerability of Obicetrapib in Participants with a History of Heterozygous Familial Hypercholesterolemia (HeFH).","primaryOutcome":{"measure":"Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline to Day 84 [PUC]","timeFrame":"84 Days","effectByArm":[{"arm":"Placebo","deltaMin":0.25,"sd":2.48},{"arm":"Obicetrapib 10 mg","deltaMin":-36.05,"sd":1.769}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":96,"countries":["United States","Canada","Czechia","Georgia","Netherlands","Norway","Poland","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["38705341"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":118},"commonTop":["Influenza","COVID-19","Hypertension","Nasopharyngitis","Diarrhea"]}}